138407-83-7

Upstream product

• 21794-55-8 (+)-Daunomycinone 
• 138432-66-3 (-)-(2R,3S,4R)-2-phenyl-3,4-bis<(trimethylsilyl)oxy>-2,3-dihydro-4H-pyran 
• 100-52-7 benzaldehyde 
• 138407-79-1 (+)-(2S,3R,4S)-2-phenyl-3,4-bis<(trimethylsilyl)oxy>-2,3-dihydro-4H-pyran 
• 138407-80-4 (2R*,3S*)-3-(benzoyloxy)-2-phenyl-2,3-dihydro-4H-pyran-4-one 
• 138512-16-0 (-)-(2R,3R,4R)-3,4-dihydroxy-2-phenyl-2,3-dihydro-4H-pyran 
• 138407-62-2 (+)-(2S,3S,4S)-3-(benzoyloxy)-4-hydroxy-2-phenyl-2,3-dihydro-4H-pyran 
• 138512-17-1 (+)-(2S,3S,4S)-3,4-dihydroxy-2-phenyl-2,3-dihydro-4H-pyran 
• 138407-63-3 (-)-(2R,3S,4R)-4-acetoxy-3-(benzoyloxy)-2-phenyl-2,3-dihydro-4H-pyran 
• 138512-01-3 (2R*,3R*,4R*)-3-(benzoyloxy)-4-hydroxy-2-phenyl-2,3-dihydro-4H-pyran 

Downstream Products

• 138407-78-0 (2'R,3'R,4'S,5'R,6'R)-7-O-<2'-(4',5'-dihydroxy-3'-iodo-6'-phenyltetrahydropyranosyl)>daunomycinone 
• 138407-78-0 (2'S,3'R,4'S,5'R,6'R)-7-O-<2'-(4',5'-dihydroxy-3'-iodo-6'-phenyltetrahydropyranosyl)>daunomycinone 
• 138512-04-6 (2'S,3'S,4'S,5'R,6'R)-7-O-<2'-(4',5'-dihydroxy-3'-iodo-6'-phenyltetrahydropyranosyl)>daunomycinone 
• 138407-78-0 (2'R,3'R,4'R,5'S,6'S)-7-O-<2'-(4',5'-dihydroxy-3'-iodo-6'-phenyltetrahydropyranosyl)>daunomycinone 
• 138407-78-0 (2'R,3'S,4'R,5'S,6'S)-7-O-<2'-(4',5'-dihydroxy-3'-iodo-6'-phenyltetrahydropyranosyl)>daunomycinone 
• 138407-78-0 (2'S,3'S,4'R,5'S,6'S)-7-O-<2'-(4',5'-dihydroxy-3'-iodo-6'-phenyltetrahydropyranosyl)>daunomycinone 

Relevant academic research and scientific papers

A route to artificial glycoconjugates and oligosaccharides via enzymatically resolved glycals: Dramatic effects of the handedness of the sugar domain upon the properties of an anthracycline drug

Racemic, fully synthetic glycals of considerable structural variety may be kinetically resolved via enzymatically mediated transesterification using Lipase PS-30 from Pseudomonas cepacia as catalyst and vinyl acetate as acyl donor. This methodology provid